Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Total Revenue of $1.30 billion for the year ending 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +27.4% in Total Revenue from 2024 to 2025.
- This data is from PHIBRO ANIMAL HEALTH CORP's annual report (Form 10-K), filed with the SEC on August 27, 2025.
- XBRL data for this metric is available from 2012 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $162.11 million | Q4 2012: $164.16 million | Q1 2013: $162.69 million | Q2 2013: $164.20 million | Q3 2013: $162.23 million | Q4 2013: $172.74 million | Q1 2014: $173.27 million | Q2 2014: $183.68 million | Q3 2014: $187.46 million | Q4 2014: $188.69 million | Q1 2015: $187.50 million | Q2 2015: $184.95 million | Q3 2015: $187.12 million | Q4 2015: $191.77 million | Q1 2016: $183.46 million | Q3 2016: $187.99 million | Q4 2016: $191.60 million | Q1 2017: $189.86 million | Q3 2017: $193.41 million | Q4 2017: $205.88 million | Q1 2018: $208.91 million | Q3 2018: $200.15 million | Q4 2018: $218.22 million | Q1 2019: $205.74 million | Q3 2019: $189.72 million | Q4 2019: $214.01 million | Q1 2020: $210.74 million | Q3 2020: $195.19 million | Q4 2020: $206.15 million | Q1 2021: $211.73 million | Q3 2021: $214.67 million | Q3 2021: $214.67 million | Q4 2021: $232.71 million | Q4 2021: $232.71 million | Q1 2022: $239.62 million | Q1 2022: $239.62 million | Q3 2022: $232.52 million | Q4 2022: $244.65 million | Q1 2023: $245.67 million | Q3 2023: $231.35 million | Q4 2023: $249.94 million | Q1 2024: $263.22 million | Q3 2024: $260.43 million | Q4 2024: $309.26 million | Q1 2025: $347.83 million | Q3 2025: $363.89 million | Q4 2025: $373.91 million.
- Over the full 16 years of available data (2012 to 2025), PHIBRO ANIMAL HEALTH CORP's Total Revenue has grown by 98.2%.
- Historical annual values: Fiscal year 2025: $1.30 billion | Fiscal year 2024: $1.02 billion | Fiscal year 2023: $977.89 million | Fiscal year 2022: $942.26 million | Fiscal year 2021: $833.35 million | Fiscal year 2021: $833.35 million | Fiscal year 2020: $800.35 million | Fiscal year 2020: $800.35 million | Fiscal year 2019: $828.00 million | Fiscal year 2018: $819.98 million | Fiscal year 2017: $764.28 million | Fiscal year 2016: $751.53 million | Fiscal year 2015: $748.59 million | Fiscal year 2014: $691.91 million | Fiscal year 2013: $653.15 million | Fiscal year 2012: $654.10 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: